Karlan BY - Search Results

1

Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy.

Powell CB, Swisher EM, Cass I, McLennan J, Norquist B, Garcia RL, Lester J, Karlan BY, Chen L. Powell CB, et al. Among authors: karlan by. Gynecol Oncol. 2013 May;129(2):364-71. doi: 10.1016/j.ygyno.2013.01.029. Epub 2013 Feb 4. Gynecol Oncol. 2013. PMID: 23391663 Free PMC article.

2

The influence of tumor grade, distribution, and extent of carcinomatosis in minimal residual stage III epithelial ovarian cancer after optimal primary cytoreductive surgery.

Farias-Eisner R, Teng F, Oliveira M, Leuchter R, Karlan B, Lagasse LD, Berek JS. Farias-Eisner R, et al. Gynecol Oncol. 1994 Oct;55(1):108-10. doi: 10.1006/gyno.1994.1257. Gynecol Oncol. 1994. PMID: 7959250

3

Conservative and individualized surgery for early squamous carcinoma of the vulva: the treatment of choice for stage I and II (T1-2N0-1M0) disease.

Farias-Eisner R, Cirisano FD, Grouse D, Leuchter RS, Karlan BY, Lagasse LD, Berek JS. Farias-Eisner R, et al. Among authors: karlan by. Gynecol Oncol. 1994 Apr;53(1):55-8. doi: 10.1006/gyno.1994.1087. Gynecol Oncol. 1994. PMID: 8175023 Clinical Trial.

4

Early detection and risk reduction for familial gynecologic cancers.

Chen LM, Karlan BY. Chen LM, et al. Among authors: karlan by. Clin Obstet Gynecol. 1998 Mar;41(1):200-14. doi: 10.1097/00003081-199803000-00025. Clin Obstet Gynecol. 1998. PMID: 9504236 Review. No abstract available.

5

Molecular advances in gynecologic oncology.

Cass I, Baldwin RL, Karlan BY. Cass I, et al. Among authors: karlan by. Curr Opin Oncol. 1999 Sep;11(5):394-400. doi: 10.1097/00001622-199909000-00013. Curr Opin Oncol. 1999. PMID: 10505778 Review.

6

Splenectomy and surgical cytoreduction for ovarian cancer.

Chen LM, Leuchter RS, Lagasse LD, Karlan BY. Chen LM, et al. Among authors: karlan by. Gynecol Oncol. 2000 Jun;77(3):362-8. doi: 10.1006/gyno.2000.5800. Gynecol Oncol. 2000. PMID: 10831343

7

Recurrent ovarian carcinoma: is there a place for surgery?

Chen LM, Karlan BY. Chen LM, et al. Among authors: karlan by. Semin Surg Oncol. 2000 Jul-Aug;19(1):62-8. doi: 10.1002/1098-2388(200007/08)19:1<62::aid-ssu10>3.0.co;2-o. Semin Surg Oncol. 2000. PMID: 10883026 Review.

8

BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study.

Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S, Karlan BY. Baldwin RL, et al. Among authors: karlan by. Cancer Res. 2000 Oct 1;60(19):5329-33. Cancer Res. 2000. PMID: 11034065

9

Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas.

Cass I, Li AJ, Runowicz CD, Fields AL, Goldberg GL, Leuchter RS, Lagasse LD, Karlan BY. Cass I, et al. Among authors: karlan by. Gynecol Oncol. 2001 Jan;80(1):56-61. doi: 10.1006/gyno.2000.6027. Gynecol Oncol. 2001. PMID: 11136570

10

Allelotype of papillary serous peritoneal carcinomas.

Cass I, Baldwin RL, Fasylova E, Fields AL, Klinger HP, Runowicz CD, Karlan BY. Cass I, et al. Among authors: karlan by. Gynecol Oncol. 2001 Jul;82(1):69-76. doi: 10.1006/gyno.2001.6176. Gynecol Oncol. 2001. PMID: 11426964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

513 results

Search Page